News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
What you need to know about Moderna’s new COVID vaccine, just approved by the FDA
Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID vaccine, but only for specific populations: all adults 65 and over and those between 12 and 64 with at least one underlying risk factor as defined by the Centers for Disease Control and Prevention.
For children, yes, the CDC’s “shared decision-making” guidance preserves the status quo in which Medicaid and U.S.
21hon MSN
Rep. Marjorie Taylor Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine, describing the move as "Not ...
Uncertainty now dominates the COVID vaccine outlook after official recommendations were stripped for a variety of groups.
The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...
The Centers for Disease Control and Prevention now says that kids with no underlying health conditions "may receive" COVID-19 ...
But in 2024, there was a prolonged summer surge in California that lasted from June through the end of September. After that ...
A new analysis published late last week in Vaccine concludes that COVID-19 vaccination averted 12,806 COVID-19 deaths among ...
In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback